Researchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...

Dozens of Ozempic, Mounjaro and Wegovy users are reporting drug-induced hepatitis, prompting medical experts to call for ...

Veru's pivot with enobosarm: groundbreaking Phase 2b results enhance GLP-1 therapy outcomes. A positive launch could yield ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

The nation's plastic surgeons report their practices are busier than ever as patients want to plump facial features affected by weight loss.

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the ...

Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report investigators who say weight loss does not fully explain the benefit.

KANSAS CITY, MISSOURI, US — Already on the path toward healthier, nutrient-dense products, the increasing popularity of GLP-1 ...

“GLP-1 agonists represent a major breakthrough in ... “They have been linked to reducing inflammation and supporting metabolic function, and this makes them more than just weight-loss aids ...

are synthetic versions of GLP-1 that can dramatically reduce hunger and improve insulin function. However, they come with several limitations: They require prescriptions and ongoing doctor supervision ...